Prime Highlights: The European Commission has approved the combination of Rybrevant (amivantamab) and Lazcluze (lazertinib)

Prime Highlights: Pfizer UK, a subsidiary of Pfizer, has introduced a new therapeutic agent, sotatercept,

Merck gains global rights to Hansoh Pharma’s experimental oral weight loss drug, HS-10535. The milestone

The Cydem VT Automated Clone Screening System, a high-throughput microbioreactor platform for automated top clone

With significant development in both PharmaLife and FreshForward, two of its specialized solutions for temperature-sensitive

In an effort to increase the number of cancer therapy choices available in both areas,

AstraZeneca increased its full-year sales and profit forecast for a second time in 2024, after

On November 4, AstraZeneca made an announcement stating that promising safety and tolerability data was

Backed by Novo Nordisk and Eli Lilly, the obesity treatment area was left relatively bereft

Tiziana Life Sciences has been granted a significant $4 million NIH award specifically for funding

Centenara Labs will be the new name taken replacing Rejuveron for the Swidish biotech company.

Pfizer Canada ULC declared that ABRYSVO™ is the publicly-funded vaccine prepared to protect senior adults